Skip to main content
Top
Published in: European Journal of Trauma and Emergency Surgery 3/2022

22-11-2021 | Laparotomy | Original Article

Dexmedetomidine and paralytic exposure after damage control laparotomy: risk factors for delirium? Results from the EAST SLEEP-TIME multicenter trial

Authors: Cassandra Krause, Eugenia Kwon, Xian Luo-Owen, Kaitlin McArthur, Meghan Cochran-Yu, Lourdes Swentek, Sigrid Burruss, David Turay, Areg Grigorian, Jeffry Nahmias, Ahsan Butt, Adam Gutierrez, Aimee LaRiccia, Michelle Kincaid, Michele N. Fiorentino, Nina Glass, Samantha Toscano, Eric Ley, Sarah R. Lombardo, Oscar D. Guillamondegui, James M. Bardes, Connie DeLa’O, Salina M. Wydo, Kyle Leneweaver, Nicholas T. Duletzke, Jade Nunez, Simon Moradian, Joseph Posluszny, Leon Naar, Haytham Kaafarani, Heidi Kemmer, Mark J. Lieser, Alexa Dorricott, Grace Chang, Zoltan Nemeth, Kaushik Mukherjee

Published in: European Journal of Trauma and Emergency Surgery | Issue 3/2022

Login to get access

Abstract

Purpose

To evaluate factors associated with ICU delirium in patients who underwent damage control laparotomy (DCL), with the hypothesis that benzodiazepines and paralytic infusions would be associated with increased delirium risk. We also sought to evaluate the differences in sedation practices between trauma (T) and non-trauma (NT) patients.

Methods

We reviewed retrospective data from 15 centers in the EAST SLEEP-TIME registry admitted from January 1, 2017 to December 31, 2018. We included all adults undergoing DCL, regardless of diagnosis, who had completed daily Richmond Agitation Sedation Score (RASS) and Confusion Assessment Method-ICU (CAM-ICU). We excluded patients younger than 18 years, pregnant women, prisoners and patients who died before the first re-laparotomy. Data collected included age, number of re-laparotomies after DCL, duration of paralytic infusion, duration and type of sedative and opioid infusions as well as daily CAM-ICU and RASS scores to analyze risk factors associated with the proportion of delirium-free/coma-free ICU days during the first 30 days (DF/CF-ICU-30) using multivariate linear regression.

Results

A 353 patient subset (73.2% trauma) from the overall 567-patient cohort had complete daily RASS and CAM-ICU data. NT patients were older (58.9 ± 16.0 years vs 40.5 ± 17.0 years [p < 0.001]). Mean DF/CF-ICU-30 days was 73.7 ± 96.4% for the NT and 51.3 ± 38.7% in the T patients (p = 0.030). More T patients were exposed to Midazolam, 41.3% vs 20.3% (p = 0.002). More T patients were exposed to Propofol, 91.0% vs 71.9% (p < 0.001) with longer infusion times in T compared to NT (71.2 ± 85.9 vs 48.9 ± 69.8 h [p = 0.017]). Paralytic infusions were also used more in T compared to NT, 34.8% vs 18.2% (p < 0.001). Using linear regression, dexmedetomidine infusion and paralytic infusions were associated with decreases in DF/CF-ICU-30, (− 2.78 (95%CI [− 5.54, − 0.024], p = 0.040) and (− 7.08 ([− 13.0, − 1.10], p = 0.020) respectively.

Conclusions

Although the relationship between paralytic use and delirium is well-established, the observation that dexmedetomidine exposure is independently associated with increased delirium and coma is novel and bears further study.
Literature
13.
go back to reference Kenes MT, Stollings JL, Wang L, Girard TD, Ely EW, Pandharipande PP. Persistence of delirium after cessation of sedatives and analgesics and impact on clinical outcomes in critically Ill patients. Pharmacother J Hum Pharmacol Drug Ther. 2017;37:1357–65. https://doi.org/10.1002/phar.2021.CrossRef Kenes MT, Stollings JL, Wang L, Girard TD, Ely EW, Pandharipande PP. Persistence of delirium after cessation of sedatives and analgesics and impact on clinical outcomes in critically Ill patients. Pharmacother J Hum Pharmacol Drug Ther. 2017;37:1357–65. https://​doi.​org/​10.​1002/​phar.​2021.CrossRef
27.
go back to reference Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, et al. The richmond agitation-sedation scale. Am J Resp Crit Care. 2002;166:1338–44.CrossRef Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, et al. The richmond agitation-sedation scale. Am J Resp Crit Care. 2002;166:1338–44.CrossRef
28.
go back to reference Shehabi Y, Bellomo R, Reade MC, Bailey M, Bass F, Howe B, et al. Early intensive care sedation predicts long-term mortality in ventilated critically Ill patients. Am J Resp Crit Care. 2012;186:724–31.CrossRef Shehabi Y, Bellomo R, Reade MC, Bailey M, Bass F, Howe B, et al. Early intensive care sedation predicts long-term mortality in ventilated critically Ill patients. Am J Resp Crit Care. 2012;186:724–31.CrossRef
39.
45.
go back to reference Abouassaly CT, Dutton WD, Zaydfudim V, Dossett LA, Nunez TC, Fleming SB et al. Postoperative neuromuscular blocker use is associated with higher primary fascial closure rates after damage control laparotomy. J Trauma [Internet]. 2010;69: 557–61. Available from http://journals.lww.com/00005373-201009000-00012 Abouassaly CT, Dutton WD, Zaydfudim V, Dossett LA, Nunez TC, Fleming SB et al. Postoperative neuromuscular blocker use is associated with higher primary fascial closure rates after damage control laparotomy. J Trauma [Internet]. 2010;69: 557–61. Available from http://​journals.​lww.​com/​00005373-201009000-00012
50.
go back to reference Girard TD, Kress JP, Fuchs BD, Thomason JWW, Schweickert WD, Pun BT et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet (London, England) [Internet]. 2008;371: 126–34. Available from https://linkinghub.elsevier.com/retrieve/pii/S0140673608601051 Girard TD, Kress JP, Fuchs BD, Thomason JWW, Schweickert WD, Pun BT et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet (London, England) [Internet]. 2008;371: 126–34. Available from https://​linkinghub.​elsevier.​com/​retrieve/​pii/​S014067360860105​1
Metadata
Title
Dexmedetomidine and paralytic exposure after damage control laparotomy: risk factors for delirium? Results from the EAST SLEEP-TIME multicenter trial
Authors
Cassandra Krause
Eugenia Kwon
Xian Luo-Owen
Kaitlin McArthur
Meghan Cochran-Yu
Lourdes Swentek
Sigrid Burruss
David Turay
Areg Grigorian
Jeffry Nahmias
Ahsan Butt
Adam Gutierrez
Aimee LaRiccia
Michelle Kincaid
Michele N. Fiorentino
Nina Glass
Samantha Toscano
Eric Ley
Sarah R. Lombardo
Oscar D. Guillamondegui
James M. Bardes
Connie DeLa’O
Salina M. Wydo
Kyle Leneweaver
Nicholas T. Duletzke
Jade Nunez
Simon Moradian
Joseph Posluszny
Leon Naar
Haytham Kaafarani
Heidi Kemmer
Mark J. Lieser
Alexa Dorricott
Grace Chang
Zoltan Nemeth
Kaushik Mukherjee
Publication date
22-11-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Trauma and Emergency Surgery / Issue 3/2022
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-021-01813-x

Other articles of this Issue 3/2022

European Journal of Trauma and Emergency Surgery 3/2022 Go to the issue